279 filings
Page 3 of 14
8-K
p4chr8w7 hzf77v
6 Apr 22
Departure of Directors or Certain Officers
5:00pm
DEFA14A
if8pp29dlj0x7yp59p
30 Mar 22
Additional proxy soliciting materials
7:56am
8-K
emu1xwoidwbg
15 Mar 22
Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update
7:09am
CT ORDER
93b1nqczkcsq
14 Mar 22
Confidential treatment order
3:30pm
S-8
ksqs3p0
1 Mar 22
Registration of securities for employees
5:02pm
8-K
5ee149w
1 Mar 22
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
7:39am
424B5
mi65jd
28 Jan 22
Prospectus supplement for primary offering
12:00am
8-K
8zql7 dye038
27 Jan 22
Entry into a Material Definitive Agreement
5:08pm
424B5
a3t8n3p
26 Jan 22
Prospectus supplement for primary offering
4:57pm
8-K
52ad2
10 Jan 22
Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full
7:05am
8-K
np7p 4hlkg917pm
22 Dec 21
Termination of a Material Definitive Agreement
4:05pm
8-K
gzowp3d3ttz
18 Nov 21
Epizyme Announces Updates to Its Board of Directors
6:42am
8-K
1f99t 9kuan9uzcne68
9 Nov 21
Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update
6:39am
8-K
qz7tst1
29 Oct 21
Departure of Directors or Certain Officers
6:49am
424B3
rmpuuy93u 27hryp
1 Oct 21
Prospectus supplement
4:28pm
EFFECT
2mdbkjx2vnz 1w
30 Sep 21
Notice of effectiveness
12:15am